Evidence map›Paper›PMID 31719534›Full record

ArticleNature communications2019

Antibody cross-reactivity accounts for widespread appearance of m

Anya V Grozhik, Anthony O Olarerin-George, Miriam Sindelar, Xing Li, Steven S Gross, Samie R Jaffrey

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Two codes of RNA editing by deamination in human diseases.Experimental & molecular medicine · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. Advances in RNA modification in myocardial fibrosis (Review).International journal of molecular medicine · 2025
    Review
  14. Article
  15. Review
  16. The Secret Life of NJournal of molecular biology · 2025
    Review
  17. ALKBH3-regulated mActa pharmaceutica Sinica. B · 2025
    Article
  18. Global analysis by LC-MS/MS ofRNA (New York, N.Y.) · 2025
    Article
  19. Article
  20. Methyladenine as a regulator of biomolecular condensation.Frontiers in molecular biosciences · 2025
    Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anya V GrozhikDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA.
Anthony O Olarerin-GeorgeDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA.ORCID http://orcid.org/0000-0002-6109-3824
Miriam SindelarDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA.
Xing LiDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA.
Steven S GrossDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA.
Samie R JaffreyDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA. srj2003@med.cornell.edu.ORCID http://orcid.org/0000-0003-3615-6958
Cornell University · US

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Institutional Career Development CoreKL2TR002385 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI YUAN-SHAN ZHU · 2017 to 2026
$13.3M
Risk Genes and Environment Interactions in NTDsP01HD067244 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI FINNELL, RICHARD H. · 2011 to 2020
$12.6M
CANCER PHARMACOLOGYT32CA062948 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LORRAINE J GUDAS · 1994 to 2026
$12.1M
New mechanisms and technologies for understanding post-transcriptional gene regulation in neuronsR35NS111631 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI SAMIE R JAFFREY · 2019 to 2026
$8.6M
HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary EndotheliumU01HL121828 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CRYSTAL, RONALD G, GROSS, STEVEN S · 2013 to 2017
$3.7M
Training Program in Developmental BiologyT32HD060600 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI BAO, ZHIRONG, STUHLMANN, HEIDI · 2010 to 2024
$3.5M
Pathways controlling mRNA translation pathways in dopaminergic neuronsR01DA037755 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI JAFFREY, SAMIE R · 2014 to 2018
$1.1M
Characterizing the transcriptome-wide location and function of 8oxoGF32GM120987 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI OLARERIN-GEORGE, ANTHONY · 2017 to 2017
$59k
NCATS NIH HHS KL2 TR002385NCATS NIH HHS UL1 TR000457NCATS NIH HHS UL1 TR002384NCI NIH HHS T32 CA062948NHLBI NIH HHS U01 HL121828NICHD NIH HHS P01 HD067244NICHD NIH HHS T32 HD060600NIDA NIH HHS R01 DA037755NIGMS NIH HHS F32 GM120987NINDS NIH HHS R35 NS111631
6 · The paper itself

Abstract

N

Indexed as

5' Untranslated RegionsAdenosineAnimalsAntibodiesBase SequenceCross ReactionsFemaleHEK293 CellsHumansMice, Inbred C57BLNucleotidesRNA CapsRNA, MessengerTranscriptome1-methyladenosine5' Untranslated RegionsAdenosineAntibodiesNucleotidesRNA CapsRNA, Messenger

Identifiers

PMID31719534
PMCPMC6851129
OpenAlexW2986901350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.